TiumBio
A drug developer working on treatments for cancer based in South Korean. Learn more
Launch date
Employees
Market cap
CAD183m
Enterprise valuation
CAD190m (Public information from Sep 2024)
Share price
KRW6180 321550.KQ
Seongnam-si Gyeonggi-do (HQ)
Authorizing premium user...